Globus Medical, Inc. (GMED)
USD 70.75
(2.79%)
USD 70.75
(2.79%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.08 Billion USD | 144.98% |
| 2022 | 2.07 Billion USD | 6.07% |
| 2021 | 1.95 Billion USD | 16.54% |
| 2020 | 1.67 Billion USD | 9.62% |
| 2019 | 1.53 Billion USD | 17.79% |
| 2018 | 1.3 Billion USD | 20.6% |
| 2017 | 1.07 Billion USD | 16.26% |
| 2016 | 927.63 Million USD | 11.21% |
| 2015 | 834.1 Million USD | 18.56% |
| 2014 | 703.54 Million USD | 24.23% |
| 2013 | 566.3 Million USD | 26.65% |
| 2012 | 447.13 Million USD | 35.75% |
| 2011 | 329.39 Million USD | 23.56% |
| 2010 | 266.57 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 5.08 Billion USD | 1.85% |
| 2024 Q2 | 4.99 Billion USD | 1.02% |
| 2024 Q1 | 4.94 Billion USD | -2.8% |
| 2023 Q3 | 5.35 Billion USD | 142.08% |
| 2023 Q2 | 2.21 Billion USD | 2.92% |
| 2023 FY | 5.08 Billion USD | 144.98% |
| 2023 Q1 | 2.14 Billion USD | 3.54% |
| 2023 Q4 | 5.08 Billion USD | -5.04% |
| 2022 Q3 | 1.97 Billion USD | 3.23% |
| 2022 Q4 | 2.07 Billion USD | 5.04% |
| 2022 FY | 2.07 Billion USD | 6.07% |
| 2022 Q1 | 1.99 Billion USD | 2.12% |
| 2022 Q2 | 1.91 Billion USD | -4.2% |
| 2021 Q3 | 1.91 Billion USD | 4.39% |
| 2021 Q4 | 1.95 Billion USD | 2.44% |
| 2021 Q2 | 1.83 Billion USD | 5.31% |
| 2021 FY | 1.95 Billion USD | 16.54% |
| 2021 Q1 | 1.73 Billion USD | 3.48% |
| 2020 Q1 | 1.47 Billion USD | -3.44% |
| 2020 Q2 | 1.46 Billion USD | -0.92% |
| 2020 Q3 | 1.54 Billion USD | 5.18% |
| 2020 Q4 | 1.67 Billion USD | 8.93% |
| 2020 FY | 1.67 Billion USD | 9.62% |
| 2019 Q2 | 1.39 Billion USD | 4.1% |
| 2019 Q1 | 1.33 Billion USD | 2.71% |
| 2019 Q3 | 1.45 Billion USD | 4.42% |
| 2019 FY | 1.53 Billion USD | 17.79% |
| 2019 Q4 | 1.53 Billion USD | 5.5% |
| 2018 FY | 1.3 Billion USD | 20.6% |
| 2018 Q1 | 1.12 Billion USD | 4.56% |
| 2018 Q4 | 1.3 Billion USD | 5.02% |
| 2018 Q3 | 1.23 Billion USD | 3.74% |
| 2018 Q2 | 1.19 Billion USD | 5.87% |
| 2017 Q3 | 1.03 Billion USD | 4.24% |
| 2017 Q1 | 960.42 Million USD | 3.53% |
| 2017 FY | 1.07 Billion USD | 16.26% |
| 2017 Q4 | 1.07 Billion USD | 3.99% |
| 2017 Q2 | 995.01 Million USD | 3.6% |
| 2016 Q3 | 901.74 Million USD | 3.71% |
| 2016 FY | 927.63 Million USD | 11.21% |
| 2016 Q4 | 927.63 Million USD | 2.87% |
| 2016 Q2 | 869.47 Million USD | 3.51% |
| 2016 Q1 | 839.98 Million USD | 0.71% |
| 2015 FY | 834.1 Million USD | 18.56% |
| 2015 Q3 | 800.66 Million USD | 4.71% |
| 2015 Q2 | 764.66 Million USD | 2.76% |
| 2015 Q1 | 744.12 Million USD | 5.77% |
| 2015 Q4 | 834.1 Million USD | 4.18% |
| 2014 FY | 703.54 Million USD | 24.23% |
| 2014 Q4 | 703.54 Million USD | 8.83% |
| 2014 Q3 | 646.43 Million USD | 4.6% |
| 2014 Q2 | 618 Million USD | 3.1% |
| 2014 Q1 | 599.42 Million USD | 5.85% |
| 2013 Q4 | 566.3 Million USD | 7.93% |
| 2013 FY | 566.3 Million USD | 26.65% |
| 2013 Q1 | 473.62 Million USD | 5.92% |
| 2013 Q2 | 498.07 Million USD | 5.16% |
| 2013 Q3 | 524.67 Million USD | 5.34% |
| 2012 Q4 | 447.13 Million USD | 7.47% |
| 2012 Q2 | 367.3 Million USD | 3.52% |
| 2012 Q1 | 354.8 Million USD | 7.72% |
| 2012 FY | 447.13 Million USD | 35.75% |
| 2012 Q3 | 416.04 Million USD | 13.27% |
| 2011 FY | 329.39 Million USD | 23.56% |
| 2011 Q4 | 329.39 Million USD | 0.0% |
| 2010 FY | 266.57 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 93.053% |
| Allurion Technologies Inc. | 71.71 Million USD | -6992.374% |
| Artivion, Inc. | 792.39 Million USD | -541.86% |
| Avanos Medical, Inc. | 1.69 Billion USD | -200.525% |
| Butterfly Network, Inc. | 304.27 Million USD | -1571.547% |
| Butterfly Network, Inc. | 304.27 Million USD | -1571.547% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 58.647% |
| Boston Scientific Corporation | 35.13 Billion USD | 85.525% |
| CONMED Corporation | 2.3 Billion USD | -121.132% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | 45.68% |
| Paragon 28, Inc. | 340.69 Million USD | -1392.838% |
| Glaukos Corporation | 940.41 Million USD | -440.834% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -651.478% |
| Integer Holdings Corporation | 2.94 Billion USD | -72.84% |
| Medtronic plc | 89.98 Billion USD | 94.348% |
| Myomo, Inc. | 14.58 Million USD | -34780.22% |
| Nevro Corp. | 635.71 Million USD | -700.06% |
| Owlet, Inc. | 44.12 Million USD | -11427.056% |
| Penumbra, Inc. | 1.55 Billion USD | -226.805% |
| Vicarious Surgical Inc. | 119.86 Million USD | -4143.211% |
| Smith & Nephew plc | 9.98 Billion USD | 49.073% |
| Sonendo, Inc. | 78.16 Million USD | -6407.271% |
| STERIS plc | 11.06 Billion USD | 54.029% |
| Stryker Corporation | 39.91 Billion USD | 87.257% |
| Vapotherm, Inc. | 77.61 Million USD | -6452.795% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 76.34% |